| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.38▼ | 2.37▼ | 2.37▼ | 2.42▼ | 2.60▼ |
| MA10 | 2.37▼ | 2.35▲ | 2.35▲ | 2.44▼ | 2.73▼ |
| MA20 | 2.37▼ | 2.37▼ | 2.41▼ | 2.60▼ | 2.60▼ |
| MA50 | 2.35▲ | 2.45▼ | 2.46▼ | 2.73▼ | 2.10▲ |
| MA100 | 2.41▼ | 2.45▼ | 2.50▼ | 2.61▼ | 1.58▲ |
| MA200 | 2.45▼ | 2.57▼ | 2.67▼ | 2.28▲ | 1.37▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.007▲ | 0.000▼ | -0.018▼ | -0.070▼ |
| RSI | 50.199▲ | 46.672▼ | 43.163▼ | 39.221▼ | 48.052▼ |
| STOCH | 77.546 | 74.434 | 56.699 | 32.384 | 22.484 |
| WILL %R | -41.667 | -33.333 | -72.093 | -83.636▼ | -91.824▼ |
| CCI | -4.511 | 71.200 | -11.577 | -173.292▼ | -101.728▼ |
|
Wednesday, April 29, 2026 07:08 AM
Connect Biopharma is rated a risky Buy, with high upside potential hinging on mid-2026 Phase 2 trial results for rademikibart. Click for this CNTB stock update.
|
|
Thursday, April 23, 2026 05:59 AM
SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on ...
|
|
Tuesday, March 03, 2026 01:00 AM
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 2.33 | 2.395 | 2.27 | 2.36 | 95,207 |
| 07/05/26 | 2.44 | 2.4799 | 2.30 | 2.33 | 127,506 |
| 06/05/26 | 2.47 | 2.55 | 2.44 | 2.48 | 67,465 |
| 05/05/26 | 2.51 | 2.59 | 2.4299 | 2.47 | 220,451 |
| 04/05/26 | 2.46 | 2.60 | 2.45 | 2.48 | 187,383 |
| 01/05/26 | 2.48 | 2.515 | 2.40 | 2.47 | 40,661 |
| 30/04/26 | 2.57 | 2.57 | 2.4184 | 2.47 | 102,428 |
| 29/04/26 | 2.43 | 2.56 | 2.3348 | 2.53 | 124,869 |
| 28/04/26 | 2.46 | 2.50 | 2.35 | 2.40 | 148,414 |
| 27/04/26 | 2.51 | 2.59 | 2.43 | 2.45 | 142,207 |
|
|
||||
|
|
||||
|
|